110 related articles for article (PubMed ID: 29473503)
1. Genetic Variants Identified from GWAS for Predisposition to Type 2 Diabetes Predict Sulfonylurea Drug Response.
Phani NM; Vohra M; Adhikari P; Nagri SK; Shashikiran U; D'Souza SC; Kalluri PRR; Satyamoorthy K; Rai PS
Curr Mol Med; 2017; 17(8):580-586. PubMed ID: 29473503
[TBL] [Abstract][Full Text] [Related]
2. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
3. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.
Mtiraoui N; Turki A; Nemr R; Echtay A; Izzidi I; Al-Zaben GS; Irani-Hakime N; Keleshian SH; Mahjoub T; Almawi WY
Diabetes Metab; 2012 Nov; 38(5):444-9. PubMed ID: 22749234
[TBL] [Abstract][Full Text] [Related]
4. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.
Chauhan G; Spurgeon CJ; Tabassum R; Bhaskar S; Kulkarni SR; Mahajan A; Chavali S; Kumar MV; Prakash S; Dwivedi OP; Ghosh S; Yajnik CS; Tandon N; Bharadwaj D; Chandak GR
Diabetes; 2010 Aug; 59(8):2068-74. PubMed ID: 20424228
[TBL] [Abstract][Full Text] [Related]
5. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W
BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism E23K (rs5219) in the KCNJ11 gene in Euro-Brazilian subjects with type 1 and 2 diabetes.
Souza SW; Alcazar LP; Arakaki PA; Santos-Weiss IC; Alberton D; Picheth G; Rego FG
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387875
[TBL] [Abstract][Full Text] [Related]
7. Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study.
Makhzoom O; Kabalan Y; Al-Quobaili F
BMC Med Genet; 2019 Jun; 20(1):107. PubMed ID: 31195986
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population.
Odgerel Z; Lee HS; Erdenebileg N; Gandbold S; Luvsanjamba M; Sambuughin N; Sonomtseren S; Sharavdorj P; Jodov E; Altaisaikhan K; Goldfarb LG
J Diabetes; 2012 Sep; 4(3):238-42. PubMed ID: 22151254
[TBL] [Abstract][Full Text] [Related]
9. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies.
Ruchat SM; Elks CE; Loos RJ; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
Acta Diabetol; 2009 Sep; 46(3):217-26. PubMed ID: 19082521
[TBL] [Abstract][Full Text] [Related]
10. Population specific impact of genetic variants in KCNJ11 gene to type 2 diabetes: a case-control and meta-analysis study.
Phani NM; Guddattu V; Bellampalli R; Seenappa V; Adhikari P; Nagri SK; D Souza SC; Mundyat GP; Satyamoorthy K; Rai PS
PLoS One; 2014; 9(9):e107021. PubMed ID: 25247988
[TBL] [Abstract][Full Text] [Related]
11. Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population.
Qian Y; Dong M; Lu F; Li H; Jin G; Hu Z; Shen C; Shen H
Mol Cell Endocrinol; 2015 May; 407():46-51. PubMed ID: 25749274
[TBL] [Abstract][Full Text] [Related]
12. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
Sesti G; Laratta E; Cardellini M; Andreozzi F; Del Guerra S; Irace C; Gnasso A; Grupillo M; Lauro R; Hribal ML; Perticone F; Marchetti P
J Clin Endocrinol Metab; 2006 Jun; 91(6):2334-9. PubMed ID: 16595597
[TBL] [Abstract][Full Text] [Related]
13. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
Omori S; Tanaka Y; Takahashi A; Hirose H; Kashiwagi A; Kaku K; Kawamori R; Nakamura Y; Maeda S
Diabetes; 2008 Mar; 57(3):791-5. PubMed ID: 18162508
[TBL] [Abstract][Full Text] [Related]
14. ADIPOQ, KCNJ11 and TCF7L2 polymorphisms in type 2 diabetes in Kyrgyz population: A case-control study.
Isakova J; Talaibekova E; Vinnikov D; Saadanov I; Aldasheva N
J Cell Mol Med; 2019 Feb; 23(2):1628-1631. PubMed ID: 30467975
[TBL] [Abstract][Full Text] [Related]
15. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.
Wang F; Han XY; Ren Q; Zhang XY; Han LC; Luo YY; Zhou XH; Ji LN
Chin Med J (Engl); 2009 Oct; 122(20):2477-82. PubMed ID: 20079163
[TBL] [Abstract][Full Text] [Related]
16. Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment.
Karaglani M; Ragia G; Panagopoulou M; Balgkouranidou I; Nena E; Kolios G; Papanas N; Manolopoulos VG; Chatzaki E
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):226-233. PubMed ID: 29396966
[TBL] [Abstract][Full Text] [Related]
17. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
Javorsky M; Klimcakova L; Schroner Z; Zidzik J; Babjakova E; Fabianova M; Kozarova M; Tkacova R; Salagovic J; Tkac I
Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.
Benrahma H; Charoute H; Lasram K; Boulouiz R; Atig RK; Fakiri M; Rouba H; Abdelhak S; Barakat A
Biochem Genet; 2014 Oct; 52(9-10):430-42. PubMed ID: 24898818
[TBL] [Abstract][Full Text] [Related]
19. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel.
Chistiakov DA; Potapov VA; Smetanina SA; Bel'chikova LN; Suplotova LA; Nosikov VV
Acta Diabetol; 2011 Sep; 48(3):227-35. PubMed ID: 21611789
[TBL] [Abstract][Full Text] [Related]
20. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
